Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kazumasa Kase
Institution:
Kanazawa University
Observed institutions:
Kanazawa University,
Kanazawa University Hospital,
Keiju Medical Center,
Kanazawa Hospital,
Komatsu (Japan)
OpenAlex ID:
A5113960707
Real-World Efficacy of First-Line Pembrolizumab in Patients With Advanced or Recurrent Non–Small-Cell Lung Cancer and High PD-L1 Tumor Expression
2020
·
Yuichi Tambo
, Takashi Sone
, et al.
·
Clinical Lung Cancer
·
35
Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings
2022
·
Taro Yoneda
, Takashi Sone
, et al.
·
Clinical Lung Cancer
·
26
Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung disease
2021
·
Satoshi Watanabe
, Kazumasa Kase
, et al.
·
Respiratory Medicine
·
22
Fractional analysis of bronchoalveolar lavage in systemic sclerosis-associated interstitial lung disease
2021
·
Kazumasa Kase
, Satoshi Watanabe
, et al.
·
Journal of Thoracic Disease
·
19
PDF
Patients with idiopathic pulmonary fibrosis and refractory cough have traction bronchiectasis and distorted airway architecture: a retrospective case review study
2024
·
Kenta Yamamura
, Johsuke Hara
, et al.
·
Journal of Thoracic Disease
·
4
Immunoglobulin G4-related disease preceded by lung involvement
2017
·
Miki Abo
, Hazuki Takato
, et al.
·
Medicine
·
3
The lung as a site for the generation of anti-MDA5 antibody in clinically amyopathic dermatomyositis
2024
·
Ryo Hara
, Satoshi Watanabe
, et al.
·
Lara D. Veeken
·
2
Comparing region of interest selection and whole-field analysis for measurement of ciliary beat frequency in high-speed video analysis
2024
·
Miki Abo
, Kousuke Imamura
, et al.
·
Respiratory Investigation
·
2
PDF
Emergence of lung cancer with a low PD-L1 expression level after the administration of immune check point inhibitor for lung adenocarcinoma with a high PD-L1 expression level: A case report
2020
·
Shun Iwai
, Aika Funasaki
, et al.
·
Annals of Medicine and Surgery
·
2
A case of gingival cancer with pulmonary metastases that developed complete atrioventricular block and ventricular fibrillation as a result of myocardial metastases
2016
·
Taro Yoneda
, Kazumasa Kase
, et al.
·
Clinical Case Reports
·
2
PDF
Anti-MDA5 antibody-positive interstitial lung disease without prominent skin or muscle manifestations: A high-risk and potentially overlooked subgroup
2025
·
Atsushi Muto
, Satoshi Watanabe
, et al.
·
Respiratory Medicine
·
1
Prognostic value of coexisting conditions and complications in pleuroparenchymal fibroelastosis: a single-center retrospective study.
2024
·
Kazuhiko Iwasaki
, Satoshi Watanabe
, et al.
·
Sarcoidosis vasculitis and diffuse lung diseases
·
1
PDF
Unexpected Diffuse Alveolar Hemorrhage After Bronchoscopy
2023
·
Saya Tsukida
, Satoshi Watanabe
, et al.
·
CHEST Journal
·
1
PDF
Neutrophils and CSF1 promote the expansion of monocyte-derived alveolar macrophages in progressive pulmonary fibrosis
2026
·
Kazumasa Kase
, Satoshi Watanabe
, et al.
·
American Journal of Physiology-Lung Cellular and Molecular Physiology
Bronchoscopic Lung Volume Reduction for Severe Chronic Obstructive Pulmonary Disease Complicated by an Airway Foreign Body: A Case Report
2026
·
Yusuke Hirao
, Satoshi Watanabe
, et al.
·
Respiratory Endoscopy
PDF
A 72-Year-Old Man With Progressive Dyspnea and Diffuse Lung Disease
2025
·
Ryo Hara
, Satoshi Watanabe
, et al.
·
CHEST Journal
MO62-7 Prognostic evaluation using cfDNA in patients with resectable lung cancer
2023
·
Yuya Murase
, Hayato Koba
, et al.
·
Annals of Oncology
PDF
Refractory bronchorrhea and mucinous pleural effusion caused by lung metastasis of pancreatic cancer
2021
·
Taro Yoneda
, Hayato Koba
, et al.
PDF
Kinetic Changes in Serum KL-6 Levels Predict Disease Progression in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Observational Study
2021
·
Satoshi Watanabe
, Kazumasa Kase
, et al.
·
Research Square
PDF
MO25-3 Long time follow-up data of first-line pembrolizumab for advanced NSCLC patients with PD-L1 TPS of 50% or greater
2021
·
Yuichi Tambo
, Takashi Sone
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
20
Citation count:
121
H-index:
4
I10-index:
4
Year
Topic
Type